Xeriant 10-K: Going Concern Warning, $3.5M Auctus Settlement Extended to Oct 31
XERI has more than doubled off its 52-week low of $0.004.
Summary
Xeriant's 10-K reiterates substantial doubt about its ability to continue as a going concern, with only ~4 months of cash runway and a $3.5M Auctus settlement still unpaid and extended to October 31, 2026.
Key Events · Earnings and Guidance · XERI
-
Going Concern Warning Reiterated
Auditor and management both state substantial doubt about Xeriant's ability to continue as a going concern. Cash of $87,594 at June 30, 2026, is expected to fund only ~4 months of operations.
-
Auctus Settlement Extended to Oct 31
The $3.5M settlement with Auctus Fund LLC — originally due in early 2026 — has been extended twice. No cash payments have been made. The latest extension includes a two-year warrant extension.
-
46.1M Shares Issued as Extension Fee
Xeriant issued 46,138,100 common shares to Auctus valued at $1,061,176 as consideration for the May 2026 extension, adding to dilution.
-
Net Income Is Non-Cash Accounting Gain
FY2026 net income of $392,278 is entirely driven by a $2,810,278 gain on debt extinguishment from the Auctus settlement — not operating performance. Operating loss was $1,058,224.
Analysis · XERI · Manufacturing
Xeriant's annual report confirms the company has roughly four months of cash remaining and a $4.9 million working capital deficit. The Auctus settlement — originally due in early 2026 — has been extended twice, most recently to October 31, 2026, with the company issuing 46.1 million shares as an extension fee. The reported net income of $392,278 is entirely non-cash, driven by a $2.8 million gain on debt extinguishment. The company has not made any cash payments on the $3.5 million settlement obligation.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XERI was trading at $0.01 on OTC in the Manufacturing sector, with a market capitalization of approximately $9.5M. The 52-week trading range was $0.00 to $0.03. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.